Healthcare

Veradermics Incorporated (NYSE:MANE) shares were trading near their 52-week high at USD 137.17 on October 21, 2026, up 7.91%. The pattern hair loss drug developer went public in February, reported male Phase 2/3 results in April, closed a follow-on offering in May, announced female …

Waters (NYSE:WAT) shares were trading near their 52-week high at USD 456.82 on October 21, 2026, up 3.16%. The laboratory instruments maker completed its combination with the BD Biosciences and Diagnostic Solutions business in February, issued $3.5 billion of senior notes in March, and …

West Pharmaceutical Services (NYSE:WST) shares were trading near their 52-week high at USD 394.97 on October 21, 2026, up 1.59%. The injectable drug packaging maker authorized a $1.0 billion buyback in February, experienced a material cybersecurity attack in May, and reported second quarter 2026 …

Bicara Therapeutics (NASDAQ:BCAX) shares are trading down 1.04% at $18.16, and the stock's 50-day simple moving average has moved below its 200-day, a pattern technical analysts call a death cross. The company has a market capitalization of $1.20 billion.

CapsoVision (NASDAQ:CV) shares are trading up 1.72% at $6.80, and the stock's 50-day simple moving average has moved above its 200-day, a pattern technical analysts call a golden cross. The company has a marketCapitalizationof $361.56 million.

Edwards Lifesciences Corporation (NYSE:EW) announced on Wednesday that the U.S. Food and Drug Administration has approved its PASCAL Precision system for tricuspid valve repair. The device is delivered through a catheter, so patients avoid open heart surgery.

Unicycive Therapeutics, Inc. (NASDAQ:UNCY) said on Wednesday that the U.S. Food and Drug Administration has accepted the resubmission of its New Drug Application for oxylanthanum carbonate, known as OLC. The agency classed it as a Class II resubmission with a six-month review and set …